Group A streptococcal necrotising fasciitis masquerading as mastitis

Lancet

Volumn 368, Issue 9530, 2006, Pages 174-

  Tillett, Rachel L ^a   Saxby, Peter J ^a   Stone, Christopher A ^a   Morgan, Marina S ^a  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; IMIPENEM; IMMUNOGLOBULIN; PENICILLIN G;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASSISTED VENTILATION; BACTERIUM EXAMINATION; BREAST INJURY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DEBRIDEMENT; EMERGENCY SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; INOTROPISM; MASTITIS; NECROTIZING FASCIITIS; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SKIN EXAMINATION; SPLIT THICKNESS SKIN GRAFT; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TREATMENT INDICATION;

EID: 33745587275     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69007-7     Document Type: Article

References (5)

1. Stevens D. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Ann Rev Med 51 (2000) 271-288
2. Kaul R., McGreer A., Norrby-Teglund A., et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. Clin Infect Dis 28 (1999) 800-807
3. Darenberg J., Ihendyane N., Sjölin J., et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37 (2003) 333-340
4. The Working Group on severe streptococcal infections. Defining the group A streptococcal toxic shock syndrome. JAMA 269 (1993) 390-391
5. Coyle E. Targeting bacterial virulence: the role of protein synthesis inhibitors in severe infections. Pharmacotherapy 23 (2003) 638-642